Bovine Based Collagen For Biomedical Applications Market: Global Industry Analysis and Forecast (2023-2029)


The Bovine Based Collagen For Biomedical Applications Market was valued $0.92 Bn in 2022 and is expected to reach $1.62 Bn by 2029, at a CAGR of 8.4%.

Market Introduction and Overview

The Bovine based Collagen for Biomedical Applications Market in the US was valued US$212 million in the year 2020. China, the fastest-growing economy is expected to reach a market value of US$290.1 million by 2026. Other global markets such as Japan and Canada are expected to grow at a CAGR of 5.5% and 7.1% respectively. Among the European nations, Germany is expected to grow at a 6.5% CAGR.Bovine Based Collagen For Biomedical Applications MarketTo know about the Research Methodology :- Request Free Sample Report

The growing demand for bovine-based collagen in biomedical applications to treat various medical conditions is driving the market growth. Increasing demand for dental and orthopedic surgeries is fuelling the growth of this market. Increasing R&D activities for the development of wound healing & regenerative medicines are likely to trigger market growth in the coming years. Moreover, factors such as massive use of the products in cartilage repairs, wound dressings, bone graft substitutes, collagen-based scaffolds, skin substitutes and hemostats, rise in geriatric population, rise in burn and trauma cases and growth in demand for bovine based collagen products are also contributing to the market growth.

The use of Bovine based collagen in biomedical applications to treat various medical conditions like arthritis, osteoporosis, and improving skin health is augmenting the market growth. Bovine is made use of in different development stages such as fetal bovine dermis used for tendon reinforcement, skin and wound healing (in the form of collagen matrix); neonatal bovine dermis is used for hernia repair, plastic and reconstructive surgery; adult bovine pericardium for hernia repair and muscle flap reinforcement. Corneal collagen shields for ocular delivery has also been reported. Bandage soft contact lenses are made of hydrophilic plastics which are widely used to protect eyes with various problems, including non-healing epithelial defects after corneal transplantation or refractive surgery and recurrent epithelial erosions after ocular herpes infection.

However, the risk of disease transmission is a major restraint for market growth.

The report contains detailed analysis of Strengths, Weakness and opportunities of the key players operating in the Bovine based Collagen for Biomedical Applications Market. It also provides information on current market trends, competitive ranking analysis, regional bifurcation, turnover forecasts, industry drivers and the key challenges.

The report has profiled ten key players in the market from different regions. However, report has considered all market leaders, followers, and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on the availability of advanced technology and new techniques.

Bovine Based Collagen For Biomedical Applications Market Segment Analysis

By applications, the bone graft substitute segment is expected to grow at a CAGR of xx% in the forecast period. Bone graft procedures have been increasingly used in traumatology, tumor surgery, spine surgery, infection, and revision arthroplasty. In the US, approximately 500,000 bone graft procedures are performedannually. Bone substitutes have a diversity of composition, mechanical strength, and functional biological mechanisms. Graft substitutes for autologous bone are an appealing alternative. Substitutes include allograft, mineral composites, ceramics, mineral cement, bioactive glass, proteins, and growth factors. The use and availability of these productshave expanded exponentially. Factors such as increased blood loss, increased anesthesia time, and increased morbidity rate are demanding the need for bone graft substitutes, thereby driving the market growth. An increase in preference for collagen as a bone substitute due to its osteoinductive activity is the key factor boosting the segment growth.

The collagen-based scaffold segment is estimated to drive at a significant CAGR of xx% in the forecast period. The regional markets such as the US, Canada, Europe, China and Japan accounted for a combined market size of US$110.9 Million in 2020. Collagen-based scaffolds have been widely used for tissue engineering of a variety of tissues such as cartilage, bone, tendon, ligament, skin, blood vessels, nerve, bladder, and tooth. A wide variety of applications in diverse fields is boosting the segment growth at a faster pace.

Bovine Based Collagen For Biomedical Applications Market Regional Insights

North America accounted for the largest share of xx% in 2022, the reason being the rising prevalence of bone-related disorders. Investments by key players in this field have boosted the market growth. Factors such as technological advancements, robust healthcare infrastructure, growing prevalence of bone disorders, and the presence of highly qualified and experienced surgeons are driving the region’s growth. Beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase the market growth.

The Asia Pacific is also expected to witness significant growth during the forecast period due to the increasing geriatric population and rising health care expenditures. The allocation of a large amount of healthcare expenditure for hospitals and dispensing medicines to the elderly is expected to drive the market demand.

The report also helps in understanding Global Bovine based Collagen for Biomedical Applications Market dynamics, structure by analysing the market segments and project the Global Bovine based Collagen for Biomedical Applications Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Bovine based Collagen for Biomedical Applications Market make the report investor’s guide.

Bovine Based Collagen For Biomedical Applications Market Scope: Inquire before Buying






Bovine Based Collagen For Biomedical Applications Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2017 to 2022
Market Size in 2022:
US $ 0.92 Bn.




Forecast Period 2023 to 2029 CAGR:
8.4%
Market Size in 2029:
US $ 1.62 Bn.




 Segments Covered:
by Applications
• Bone graft substitute
• Cartilage repair
• Collagen-based scaffold
• Hemostat
• Skin substitute




by Distribution Channel
• Hospital pharmacies
• Ambulatory centers




by Region
• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)






Bovine Based Collagen For Biomedical Applications Market Key Players

• BBI Solutions
• Symatese
• Gurnet Point Capital
• Viscofan BioEngineering (a part of Naturin Viscofan GmbH)
• Collagen Solutions LLP
• Botiss biomaterials GmbH
• Medtronic
• Taxus Cardium
• KYERON
• Collagen Matrix, Inc.

Frequently Asked Questions:

1. Which region has the largest share in Global Bovine Based Collagen For Biomedical Applications Market?
Ans: North America region held the highest share in 2022.

2. What is the growth rate of Global Bovine Based Collagen For Biomedical Applications Market?
Ans: The Global Bovine Based Collagen For Biomedical Applications Market is growing at a CAGR of 8.4% during forecasting period 2023-2029.

3. What is scope of the Global Bovine Based Collagen For Biomedical Applications Market report?
Ans: Global Bovine Based Collagen For Biomedical Applications Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Bovine Based Collagen For Biomedical Applications Market?
Ans: The important key players in the Global Bovine Based Collagen For Biomedical Applications Market are – BBI Solutions, Symatese, Gurnet Point Capital, Viscofan BioEngineering (a part of Naturin Viscofan GmbH), Collagen Solutions LLP, Botiss biomaterials GmbH, Medtronic, Taxus Cardium, KYERON, Collagen Matrix, Inc.

5. What is the study period of this Market?
Ans: The Global Bovine Based Collagen For Biomedical Applications Market is studied from 2022 to 2029. 





Bovine based Collagen for Biomedical Applications Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Market Size, By Market Value (US$ Mn)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
5. Supply Side and Demand Side Indicators
6. Global Bovine based Collagen for Biomedical Applications Market Analysis and Forecast
6.1. Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America
7. Global Bovine based Collagen for Biomedical Applications Market Analysis and Forecast, By Applications
7.1. Introduction and Definition
7.2. Key Findings
7.3. Market Value Share Analysis, By Applications
7.4. Market Size (US$ Mn) Forecast, By Applications
7.5. Market Analysis, By Applications
7.6. Market Attractiveness Analysis, By Applications
8. Global Bovine based Collagen for Biomedical Applications Market Analysis and Forecast, By Distribution Channel
8.1. Introduction and Definition
8.2. Key Findings
8.3. Market Value Share Analysis, By Distribution Channel
8.4. Market Size (US$ Mn) Forecast, By Distribution Channel
8.5. Market Analysis, By Distribution Channel
8.6. Market Attractiveness Analysis, By Distribution Channel
9. Global Bovine based Collagen for Biomedical Applications Market Analysis, By Region
9.1. Market Value Share Analysis, By Region
9.2. Market Size (US$ Mn) Forecast, By Region
9.3. Market Attractiveness Analysis, By Region
10. North America Bovine based Collagen for Biomedical Applications Market Analysis
10.1. Key Findings
10.2. North America Market Overview
10.3. North America Market Value Share Analysis, By Applications
10.4. North America Market Forecast, By Applications
10.4.1. Bone graft substitute
10.4.2. Cartilage repair
10.4.3. Collagen-based scaffold
10.4.4. Hemostat
10.4.5. Skin substitute
10.5. North America Market Value Share Analysis, By Distribution Channel
10.6. North America Market Forecast, By Distribution Channel
10.6.1. Hospital pharmacies
10.6.2. Ambulatory centers
10.7. North America Market Value Share Analysis, By Country
10.8. North America Market Forecast, By Country
10.8.1. U.S.
10.8.2. Canada
10.8.3. Mexico
10.9. North America Market Analysis, By Country
10.10. U.S. Market Forecast, By Applications
10.10.1. Bone graft substitute
10.10.2. Cartilage repair
10.10.3. Collagen-based scaffold
10.10.4. Hemostat
10.10.5. Skin substitute
10.11. U.S. Market Forecast, By Distribution Channel
10.11.1. Hospital pharmacies
10.11.2. Ambulatory centers
10.12. Canada Market Forecast, By Applications
10.12.1. Bone graft substitute
10.12.2. Cartilage repair
10.12.3. Collagen-based scaffold
10.12.4. Hemostat
10.12.5. Skin substitute
10.13. Canada Market Forecast, By Distribution Channel
10.13.1. Hospital pharmacies
10.13.2. Ambulatory centers
10.14. Mexico Market Forecast, By Applications
10.14.1. Bone graft substitute
10.14.2. Cartilage repair
10.14.3. Collagen-based scaffold
10.14.4. Hemostat
10.14.5. Skin substitute
10.15. Mexico Market Forecast, By Distribution Channel
10.15.1. Hospital pharmacies
10.15.2. Ambulatory centers
10.16. North America Market Attractiveness Analysis
10.16.1. By Applications
10.16.2. By Distribution Channel
10.17. PEST Analysis
10.18. Key Trends
10.19. Key Developments
11. Europe Bovine based Collagen for Biomedical Applications Market Analysis
11.1. Key Findings
11.2. Europe Market Overview
11.3. Europe Market Value Share Analysis, By Applications
11.4. Europe Market Forecast, By Applications
11.4.1. Bone graft substitute
11.4.2. Cartilage repair
11.4.3. Collagen-based scaffold
11.4.4. Hemostat
11.4.5. Skin substitute
11.5. Europe Market Value Share Analysis, By Distribution Channel
11.6. Europe Market Forecast, By Distribution Channel
11.6.1. Hospital pharmacies
11.6.2. Ambulatory centers
11.7. Europe Market Value Share Analysis, By Country
11.8. Europe Market Forecast, By Country
11.8.1. Germany
11.8.2. U.K.
11.8.3. France
11.8.4. Italy
11.8.5. Spain
11.8.6. Sweden
11.8.7. CIS countries
11.8.8. Rest of Europe
11.9. Germany Market Forecast, By Applications
11.9.1. Bone graft substitute
11.9.2. Cartilage repair
11.9.3. Collagen-based scaffold
11.9.4. Hemostat
11.9.5. Skin substitute
11.10. Germany Market Forecast, By Distribution Channel
11.10.1. Hospital pharmacies
11.10.2. Ambulatory centers
11.11. U.K. Market Forecast, By Applications
11.11.1. Bone graft substitute
11.11.2. Cartilage repair
11.11.3. Collagen-based scaffold
11.11.4. Hemostat
11.11.5. Skin substitute
11.12. U.K. Market Forecast, By Distribution Channel
11.12.1. Hospital pharmacies
11.12.2. Ambulatory centers
11.13. France Market Forecast, By Applications
11.13.1. Bone graft substitute
11.13.2. Cartilage repair
11.13.3. Collagen-based scaffold
11.13.4. Hemostat
11.13.5. Skin substitute
11.14. France Market Forecast, By Distribution Channel
11.14.1. Hospital pharmacies
11.14.2. Ambulatory centers
11.15. Italy Market Forecast, By Applications
11.15.1. Bone graft substitute
11.15.2. Cartilage repair
11.15.3. Collagen-based scaffold
11.15.4. Hemostat
11.15.5. Skin substitute
11.16. Italy Market Forecast, By Distribution Channel
11.16.1. Hospital pharmacies
11.16.2. Ambulatory centers
11.17. Spain Market Forecast, By Applications
11.17.1. Bone graft substitute
11.17.2. Cartilage repair
11.17.3. Collagen-based scaffold
11.17.4. Hemostat
11.17.5. Skin substitute
11.18. Spain Market Forecast, By Distribution Channel
11.18.1. Hospital pharmacies
11.18.2. Ambulatory centers
11.19. Sweden Market Forecast, By Applications
11.19.1. Bone graft substitute
11.19.2. Cartilage repair
11.19.3. Collagen-based scaffold
11.19.4. Hemostat
11.19.5. Skin substitute
11.20. Sweden Market Forecast, By Distribution Channel
11.20.1. Hospital pharmacies
11.20.2. Ambulatory centers
11.21. CIS countries Market Forecast, By Applications
11.21.1. Bone graft substitute
11.21.2. Cartilage repair
11.21.3. Collagen-based scaffold
11.21.4. Hemostat
11.21.5. Skin substitute
11.22. CIS countries Market Forecast, By Distribution Channel
11.22.1. Hospital pharmacies
11.22.2. Ambulatory centers
11.23. Rest of Europe Market Forecast, By Applications
11.23.1. Bone graft substitute
11.23.2. Cartilage repair
11.23.3. Collagen-based scaffold
11.23.4. Hemostat
11.23.5. Skin substitute
11.24. Rest of Europe Market Forecast, By Distribution Channel
11.24.1. Hospital pharmacies
11.24.2. Ambulatory centers
11.25. Europe Market Attractiveness Analysis
11.25.1. By Distribution Channel
11.25.2. By Applications
11.26. PEST Analysis
11.27. Key Trends
11.28. Key Developments
12. Asia Pacific Bovine based Collagen for Biomedical Applications Market Analysis
12.1. Key Findings
12.2. Asia Pacific Market Overview
12.3. Asia Pacific Market Value Share Analysis, By Applications
12.4. Asia Pacific Market Forecast, By Applications
12.4.1. Bone graft substitute
12.4.2. Cartilage repair
12.4.3. Collagen-based scaffold
12.4.4. Hemostat
12.4.5. Skin substitute
12.5. Asia Pacific Market Value Share Analysis, By Distribution Channel
12.6. Asia Pacific Market Forecast, By Distribution Channel
12.6.1. Hospital pharmacies
12.6.2. Ambulatory centers
12.7. Asia Pacific Market Value Share Analysis, By Country
12.8. Asia Pacific Market Forecast, By Country
12.8.1. China
12.8.2. India
12.8.3. Japan
12.8.4. South Korea
12.8.5. Australia
12.8.6. ASEAN
12.8.7. Rest of Asia Pacific
12.9. Asia Pacific Market Analysis, By Country
12.10. China Market Forecast, By Applications
12.10.1. Bone graft substitute
12.10.2. Cartilage repair
12.10.3. Collagen-based scaffold
12.10.4. Hemostat
12.10.5. Skin substitute
12.11. China Market Forecast, By Distribution Channel
12.11.1. Hospital pharmacies
12.11.2. Ambulatory centers
12.12. India Market Forecast, By Applications
12.12.1. Bone graft substitute
12.12.2. Cartilage repair
12.12.3. Collagen-based scaffold
12.12.4. Hemostat
12.12.5. Skin substitute
12.13. India Market Forecast, By Distribution Channel
12.13.1. Hospital pharmacies
12.13.2. Ambulatory centers
12.14. Japan Market Forecast, By Applications
12.14.1. Bone graft substitute
12.14.2. Cartilage repair
12.14.3. Collagen-based scaffold
12.14.4. Hemostat
12.14.5. Skin substitute
12.15. Japan Market Forecast, By Distribution Channel
12.15.1. Hospital pharmacies
12.15.2. Ambulatory centers
12.16. South Korea Market Forecast, By Applications
12.16.1. Bone graft substitute
12.16.2. Cartilage repair
12.16.3. Collagen-based scaffold
12.16.4. Hemostat
12.16.5. Skin substitute
12.17. South Korea Market Forecast, By Distribution Channel
12.17.1. Hospital pharmacies
12.17.2. Ambulatory centers
12.18. Australia Market Forecast, By Applications
12.18.1. Bone graft substitute
12.18.2. Cartilage repair
12.18.3. Collagen-based scaffold
12.18.4. Hemostat
12.18.5. Skin substitute
12.19. Australia Market Forecast, By Distribution Channel
12.19.1. Hospital pharmacies
12.19.2. Ambulatory centers
12.20. ASEAN Market Forecast, By Applications
12.20.1. Bone graft substitute
12.20.2. Cartilage repair
12.20.3. Collagen-based scaffold
12.20.4. Hemostat
12.20.5. Skin substitute
12.21. ASEAN Market Forecast, By Distribution Channel
12.21.1. Hospital pharmacies
12.21.2. Ambulatory centers
12.22. Rest of Asia Pacific Market Forecast, By Applications
12.22.1. Bone graft substitute
12.22.2. Cartilage repair
12.22.3. Collagen-based scaffold
12.22.4. Hemostat
12.22.5. Skin substitute
12.23. Rest of Asia Pacific Market Forecast, By Distribution Channel
12.23.1. Hospital pharmacies
12.23.2. Ambulatory centers
12.24. Asia Pacific Market Attractiveness Analysis
12.24.1. By Applications
12.24.2. By Distribution Channel
12.25. PEST Analysis
12.26. Key Trends
12.27. Key Developments
13. Middle East & Africa Bovine based Collagen for Biomedical Applications Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Market Overview
13.3. Middle East & Africa Market Value Share Analysis, By Applications
13.4. Middle East & Africa Market Forecast, By Applications
13.4.1. Bone graft substitute
13.4.2. Cartilage repair
13.4.3. Collagen-based scaffold
13.4.4. Hemostat
13.4.5. Skin substitute
13.5. Middle East & Africa Market Value Share Analysis, By Distribution Channel
13.6. Middle East & Africa Market Forecast, By Distribution Channel
13.6.1. Hospital pharmacies
13.6.2. Ambulatory centers
13.7. Middle East & Africa Market Value Share Analysis, By Country
13.8. Middle East & Africa Market Forecast, By Country
13.8.1. GCC Countries
13.8.2. South Africa
13.8.3. Nigeria
13.8.4. Egypt
13.8.5. Rest of Middle East & Africa
13.9. Middle East & Africa Market Analysis, By Country
13.10. GCC Countries Market Forecast, By Applications
13.10.1. Bone graft substitute
13.10.2. Cartilage repair
13.10.3. Collagen-based scaffold
13.10.4. Hemostat
13.10.5. Skin substitute
13.11. GCC Countries Market Forecast, By Distribution Channel
13.11.1. Hospital pharmacies
13.11.2. Ambulatory centers
13.12. South Africa Market Forecast, By Applications
13.12.1. Bone graft substitute
13.12.2. Cartilage repair
13.12.3. Collagen-based scaffold
13.12.4. Hemostat
13.12.5. Skin substitute
13.13. South Africa Market Forecast, By Distribution Channel
13.13.1. Hospital pharmacies
13.13.2. Ambulatory centers
13.14. Nigeria Market Forecast, By Applications
13.14.1. Bone graft substitute
13.14.2. Cartilage repair
13.14.3. Collagen-based scaffold
13.14.4. Hemostat
13.14.5. Skin substitute
13.15. Nigeria Market Forecast, By Distribution Channel
13.15.1. Hospital pharmacies
13.15.2. Ambulatory centers
13.16. Egypt Market Forecast, By Applications
13.16.1. Bone graft substitute
13.16.2. Cartilage repair
13.16.3. Collagen-based scaffold
13.16.4. Hemostat
13.16.5. Skin substitute
13.17. Egypt Market Forecast, By Distribution Channel
13.17.1. Hospital pharmacies
13.17.2. Ambulatory centers
13.18. Rest of Middle East & Africa Market Forecast, By Applications
13.18.1. Bone graft substitute
13.18.2. Cartilage repair
13.18.3. Collagen-based scaffold
13.18.4. Hemostat
13.18.5. Skin substitute
13.19. Rest of Middle East & Africa Market Forecast, By Distribution Channel
13.19.1. Hospital pharmacies
13.19.2. Ambulatory centers
13.20. Middle East & Africa Market Attractiveness Analysis
13.20.1. By Applications
13.20.2. By Distribution Channel
13.21. PEST Analysis
13.22. Key Trends
13.23. Key Developments
14. South America Bovine based Collagen for Biomedical Applications Market Analysis
14.1. Key Findings
14.2. South America Market Overview
14.3. South America Market Value Share Analysis, By Applications
14.4. South America Market Forecast, By Applications
14.4.1. Bone graft substitute
14.4.2. Cartilage repair
14.4.3. Collagen-based scaffold
14.4.4. Hemostat
14.4.5. Skin substitute
14.5. South America Market Value Share Analysis, By Distribution Channel
14.6. South America Market Forecast, By Distribution Channel
14.6.1. Hospital pharmacies
14.6.2. Ambulatory centers
14.7. South America Market Value Share Analysis, By Country
14.8. South America Market Forecast, By Country
14.8.1. Brazil
14.8.2. Colombia
14.8.3. Argentina
14.8.4. Rest of South America
14.9. South America Market Analysis, By Country
14.10. Brazil Market Forecast, By Applications
14.10.1. Bone graft substitute
14.10.2. Cartilage repair
14.10.3. Collagen-based scaffold
14.10.4. Hemostat
14.10.5. Skin substitute
14.11. Brazil Market Forecast, By Distribution Channel
14.11.1. Hospital pharmacies
14.11.2. Ambulatory centers
14.12. Colombia Market Forecast, By Applications
14.12.1. Bone graft substitute
14.12.2. Cartilage repair
14.12.3. Collagen-based scaffold
14.12.4. Hemostat
14.12.5. Skin substitute
14.13. Colombia Market Forecast, By Distribution Channel
14.13.1. Hospital pharmacies
14.13.2. Ambulatory centers
14.14. Argentina Market Forecast, By Applications
14.14.1. Bone graft substitute
14.14.2. Cartilage repair
14.14.3. Collagen-based scaffold
14.14.4. Hemostat
14.14.5. Skin substitute
14.15. Argentina Market Forecast, By Distribution Channel
14.15.1. Hospital pharmacies
14.15.2. Ambulatory centers
14.16. Rest of South America Market Forecast, By Applications
14.16.1. Bone graft substitute
14.16.2. Cartilage repair
14.16.3. Collagen-based scaffold
14.16.4. Hemostat
14.16.5. Skin substitute
14.17. Rest of South America Market Forecast, By Distribution Channel
14.17.1. Hospital pharmacies
14.17.2. Ambulatory centers
14.18. South America Market Attractiveness Analysis
14.18.1. By Applications
14.18.2. By Distribution Channel
14.19. PEST Analysis
14.20. Key Trends
14.21. Key Developments
15. Company Profiles
15.1. Market Share Analysis, By Company
15.2. Competition Matrix
15.2.1. Competitive Benchmarking of key players By price, presence, market share, Distribution Channel, and R&D investment
15.2.2. New Product Launches and Product Enhancements
15.2.3. Market Consolidation
15.2.3.1. M&A By Regions, Investment and Distribution Channel
15.2.3.2. M&A Key Players, Forward Integration and Backward Integration
15.3. Company Profiles: Key Players
15.3.1. BBI Solutions
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategy
15.3.1.5. Recent Developments
15.3.1.6. Development Footprint
15.3.2. Symatese
15.3.3. Gurnet Point Capital
15.3.4. Viscofan BioEngineering
15.3.5. Collagen Solutions
15.3.6. Botiss biomaterials GmbH
15.3.7. Medtronic
15.3.8. Taxus Cardium
15.3.9. KYERON
15.3.10. Collagen Matrix, Inc.
15.3.11. Others
  • INQUIRE BEFORE BUYING